Literature DB >> 8866975

Acute behavioral effects of MK-801 in the mouse.

G Brosnan-Watters1, D F Wozniak, A Nardi, J W Olney.   

Abstract

The acute effects of 0.05 mg/kg MK-801 on spatial learning and memory in male mice were studied using a modified hole board food search task. Dose-response sensorimotor and activity tests suggested that this dose of MK-801 did not induce significant nonassociative effects. Mice were trained on the hole board using a massed trials protocol to learn the location of a hole baited with a food reward among four corner holes. Retention was tested 24 h later. Mice were split into two groups matched according to acquisition scores. The following week, mice injected with 0.05 mg/kg MK-801 30 min before being trained to a different baited hole were significantly impaired in acquiring a new baited hole location compared to saline-treated mice, although retention performance was unaffected. The same result was found in another experiment in which treatments were crossed over, and a different version of the task was used. However, in another experiment, 0.05 mg/kg MK-801 did not impair performance when the hole board task was well learned.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866975     DOI: 10.1016/0091-3057(95)02073-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice.

Authors:  M L Schaefer; S T Wong; D F Wozniak; L M Muglia; J A Liauw; M Zhuo; A Nardi; R E Hartman; S K Vogt; C E Luedke; D R Storm; L J Muglia
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

2.  The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats.

Authors:  Mark E Bardgett; Megan Points; Jennifer Kleier; Meredith Blankenship; Molly S Griffith
Journal:  Neuropharmacology       Date:  2010-07-16       Impact factor: 5.250

3.  Overdose of the histamine H₃ inverse agonist pitolisant increases thermal pain thresholds.

Authors:  Dong Dong Zhang; Marco Sisignano; Claus Dieter Schuh; Kerstin Sander; Holger Stark; Klaus Scholich
Journal:  Inflamm Res       Date:  2012-07-21       Impact factor: 4.575

4.  Effects of the H(3) antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats.

Authors:  Mark E Bardgett; Megan Points; John Roflow; Meredith Blankenship; Molly S Griffith
Journal:  Psychopharmacology (Berl)       Date:  2009-05-23       Impact factor: 4.530

5.  Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient mice.

Authors:  N Ho; J A Liauw; F Blaeser; F Wei; S Hanissian; L M Muglia; D F Wozniak; A Nardi; K L Arvin; D M Holtzman; D J Linden; M Zhuo; L J Muglia; T A Chatila
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.709

6.  A neuroligin-1-derived peptide stimulates phosphorylation of the NMDA receptor NR1 subunit and rescues MK-801-induced decrease in long-term potentiation and memory impairment.

Authors:  Irina Korshunova; Michelle D Gjørlund; Sylwia Owczarek; Anders V Petersen; Jean-François Perrier; Casper René Gøtzsche; Vladimir Berezin
Journal:  Pharmacol Res Perspect       Date:  2015-03-13

7.  Identification and functional evaluation of GRIA1 missense and truncation variants in individuals with ID: An emerging neurodevelopmental syndrome.

Authors:  Vardha Ismail; Linda G Zachariassen; Annie Godwin; Mane Sahakian; Sian Ellard; Karen L Stals; Emma Baple; Kate Tatton Brown; Nicola Foulds; Gabrielle Wheway; Matthew O Parker; Signe M Lyngby; Miriam G Pedersen; Julie Desir; Allan Bayat; Maria Musgaard; Matthew Guille; Anders S Kristensen; Diana Baralle
Journal:  Am J Hum Genet       Date:  2022-06-07       Impact factor: 11.043

8.  Recapitulation of Neuropsychiatric Behavioral Features in Mice Using Acute Low-dose MK-801 Administration.

Authors:  Darine Froy N Mabunga; Donghyun Park; Onjeon Ryu; Schley T Valencia; Keremkleroo Jym L Adil; Seonmin Kim; Kyoung Ja Kwon; Chan Young Shin; Se Jin Jeon
Journal:  Exp Neurobiol       Date:  2019-12-31       Impact factor: 3.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.